Anterior Uveitis Treatment Market – Top Players are Novartis AG, Santen Pharmaceutical Co., Ltd., AbbVie Inc., EyeGate, Clearside Biomedical, Aldeyra Therapeutics, Aciont

Anterior Uveitis Treatment Market

The Anterior Uveitis Treatment market research report is a progressive research manual on Pharmaceutical industry which is unique and creative, and proving beneficial for increasingly number of private players entering the business. This report aims to help the readers always to make informed decisions and leverage new opportunities by providing the information about the volume and share at worldwide level, territorial level and local level. From a worldwide point of view, this report speaks to Anterior Uveitis Treatment market size by dissecting chronicled information and future prospect. It endeavors to provide business-centric and value-added information to the readers so that they can witness success in this competitive Anterior Uveitis Treatment market.

Global Anterior Uveitis Treatment Market is set to witness a substantial CAGR of 5.55% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing cases of anterior uveitis and rising healthcare expenditure are the factor for the growth of this market.

Anterior uveitis is a condition which causes inflammation in the middle layer of the eyes. This disease can cause glaucoma, retinal edema and cataract which can further damage the eyes permanent and vision loss as well. Some of the common symptoms of this condition are red & sore eyes, blurred vision, small pupil and light sensitivity. This disease can be treated by treatment such as cycloplegic, anti- TNF agents, cycloplegic and others. It usually occurs whenever eyes go through any trauma.

Request for FREE Sample Report @

Market Drivers

  • Rising aging population will drive the market growth
  • Increasing cases of the optical infections will also accelerate the market growth
  • Growing disposable income will also enhance the growth of this market
  • Favorable government regulations will also contribute as a factor accelerating the growth of this market

Segmentation: Global Anterior Uveitis Treatment Market

By Treatment

  • Corticosteroids
  • Cycloplegic
  • Anti- TNF Agents
  • Immunosuppressants

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Browse Full Report with Details TOC @

Key Developments in the Market:

  • In July 2019, Aldeyra Therapeutics, Inc. announced the results from the noninfectious anterior uveitis SOLACE Trial. The results of the SOLACE Trial shows the ability of the reproxalap to treat ocular inflammation, and also demonstrated highly statistically significant immune-modulating activity in the Phase 3 ALLEVIATE Trial and Phase 2b Dry Eye Disease trial. The company is planning to develop in ocular programs in allergic conjunctivitis, dry eye disease and other
  • In March 2018, pSivida Corp. announced the acquisition of Icon Bioscience Inc and said that they will rebrand as EyePoint Pharmaceuticals. This rebranding will help the company to change from a research and development company to a biopharmaceutical company. This acquisition will help company to strengthen their position in the market. The company also partnered with two finance companies, EW Healthcare Partners and SWK Holdings Corporation, to fund the commercial development of Dexycu and Durasert

Competitive Analysis:

Global anterior uveitis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of anterior uveitis treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Inquiry before Buying @

Key Market Competitors:

Few of the major competitors currently working in the global anterior uveitis treatment market are Bausch & Lomb Incorporated, Novartis AG, Santen Pharmaceutical Co., Ltd., AbbVie Inc., EyeGate, Clearside Biomedical, Aldeyra Therapeutics, Aciont Inc., Sirion Therapeutics, Inc., EyePoint Pharmaceuticals, UAB Health System and others.

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing [email protected] . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475
Mail: [email protected]

Report Rating